InfectivologyNews.net

Infectivology Xagena

AbbVie has announced the completion of its phase III clinical program and released results of four additional studies designed to assess investigational all-oral, interferon-free therapy with and with ...


The objective of a study was to evaluate the efficacy of Ivermectin and combined Ivermectin and Metronidazole therapy in the treatment of ocular and skin lesions of Demodex folliculorum. One hundre ...


Scarce data are available to assess sexual behaviour of individuals using antiretroviral pre-exposure prophylaxis for HIV prevention. Increased sexual risk taking by individuals using effective HIV pr ...


Respiratory syncytial virus ( RSV ) infection is associated with subsequent recurrent wheeze. Observational studies cannot determine whether RSV infection is the cause of recurrent wheeze or the first ...


Recurrent Clostridium difficile infection is difficult to treat, and failure rates for antibiotic therapy are high. Researches have studied the effect of duodenal infusion of donor feces in patients w ...


The Committee for Medicinal Products for Human Use ( CHMP ) has adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product HyQvia, 100 mg/ml, solution ...


Sovaldi ( Sofosbuvir ) is the first-in-class medicine that provides the first interferon-free treatment option in patients chronic hepatitis C.Hepatitis C virus ( HCV ) infection is a major European p ...


New data from its phase III clinical trial programme, STARTVerso, which is evaluating Faldaprevir in combination with Pegylated Interferon and Ribavirin ( PegIFN/RBV ) were presented at the 64th Annua ...


Gilead Sciences has announced results from two phase 2 studies evaluating an all-oral treatment regimen of the investigational once-daily nucleotide analogue Sofosbuvir plus Ribavirin ( RBV ) for both ...


The 2-year follow-up results for a randomized placebo-controlled study of 47 patients with multidrug-resistant pulmonary tuberculosis treated with either the new diarylquinoline Bedaquiline ( TMC207; ...


The way the body metabolizes an anti-retroviral drug that is used long term by patients infected with virus HIV may contribute to cognitive impairment by damaging nerve cells.Nearly 50 percent of peop ...


Gilead Sciences has announced that the Antiviral Drugs Advisory Committee of the FDA ( Food and Drug Administration ) has voted to support approval of once-daily oral Truvada ( Emtricitabine and Tenof ...


Repeated use of an antibiotic that is considered generally benign, because users seldom incur obvious side effects, induces cumulative and persistent changes in the composition of the beneficial micro ...


A study to assess the adverse effects of anti-retroviral drugs has shown that two widely-used HIV drugs are associated with an increased risk of myocardial infarction and formation of blood clots in ...


Adverse events from antibiotics cause an estimated 142,000 emergency department ( ED ) visits per year in the United States, according to a study published in the Clinical Infectious Diseases. ...